Non-Hodgkin Lymphoma Treatment Information
“Non-Hodgkin lymphoma” is a term used to describe a group of cancers that develop when the white blood cells in the lymphatic system (lymphocytes) undergo abnormal changes that cause them to grow uncontrollably. Left untreated, these cancerous cells can form tumors, crowd out healthy white blood cells (which produce antibodies to help the body fight off infections) and ultimately weaken the body’s immune system.
In general, non-Hodgkin lymphoma is broadly classified as B-cell (bone marrow) or T-cell (thymus) lymphoma. There are also several different subtypes of each classification; some are very aggressive, while others are slower growing. The cancer subtype is usually determined by the specific type of lymphocyte involved, each of which has a specific role in protecting the body from infection: B-cells produce antibodies that target and bind to bacteria; cytotoxic T-cells target and destroy cells that are infected with bacteria; and “helper” T-cells boost the function of both B-cells and cytotoxic T-cells.
Because each subtype of non-Hodgkin lymphoma requires a different treatment method, patients are encouraged to seek treatment at a high-volume cancer center. Moffitt Cancer Center offers a full range of advanced therapies for a variety of blood cancers, including lymphomas.
At Moffitt, our renowned Malignant Hematology Program is home to a multispecialty lymphoma team, which focuses on the diagnosis and treatment of Hodgkin and non-Hodgkin lymphoma. Our comprehensive team includes:
- Board-certified surgeons
- Medical oncologists
- Radiation oncologists
- Supportive care providers
- Other medical professionals
Moffitt’s tumor board utilizes innovative techniques and state-of-the-art technologies to diagnose each patient’s specific type and stage of non-Hodgkin lymphoma. Based on the patient’s diagnosis and other unique factors, these specialists collaboratively develop a highly individualized treatment plan, then monitor the patient’s progress on an ongoing basis, refining the treatment protocol as appropriate. In a single, convenient location, Moffitt’s patients have access to all aspects of lymphoma treatment and support, including promising new therapies available only through our outstanding clinical trials program.
Moffitt is committed to continually exploring new and better ways to detect and treat lymphoma. In recognition of our extensive research efforts, we have been designated a Comprehensive Cancer Center by the National Cancer Institute, and we are the only cancer center based in Florida that has received this prestigious recognition.
For more information about non-Hodgkin lymphoma, call 1-888-MOFFITT or request an appointment by completing a new patient registration form online. We do not require referrals.